Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites

Summary1.In rat brain cortex slices preincubated with [3H]5-HT, the potencies of 17 5-HT receptor agonists to inhibit the electrically evoked3H overflow and the affinities of 13 antagonists (including several β-adrenoceptor blocking agents) to antagonize competitively the inhibitory effect of unlabelled 5-HT on evoked3H overflow were determined.2.The affinities of the compounds for 5-HT1B and 5-HT2 binding sites in rat brain cortex membranes (labelled by [125I]cyanopindolol = [125I]-CYP in the presence of 30 μmol/l isoprenaline and [3H]ketanserin, respectively), for 5-HT1A binding sites in pig and rat brain cortex membranes (labelled by [3H]8-hydroxy-2-(di-n-propylamino)tetralin = [3H]8-OH-DPAT) and for 5-HT1C binding sites in pig choroid plexus membranes (labelled by [3H]mesulergine) were also determined. The affinities of the drugs for the various 5-HT recognition sites ranged over 4–5 log units (the functional experiments revealed the same range of differences between the drugs).3.There were no significant correlations between the affinities of the drugs at 5-HT1C and 5-HT2 binding sites and their potencies or affinities, determined for the 5-HT autoreceptors. In contrast, significant correlations were found between the potencies or affinities of the drugs for the autoreceptors and their affinities at 5-HT1A or 5-HT1B binding sites; the best correlations were obtained with the 5-HT1B binding site.4.Some of the drugs investigated were not included in the correlation since their agonistic or antagonistic effects on the autoreceptors were weak and pEC30 or apparent pA2 values could not be determined (<5.5). Among these drugs, 8-OH-DPAT, TVX Q 7821 (2-(4-(4-(2-pyrimidin-yl)-1-piperazinyl)-butyl)-1,2-benzisothiazol-3(2H)one-1,1-dioxide) and spiperone showed a very low affinity for 5-HT1B binding sites (pKD<5.3), but a high affinity for 5-HT1A binding sites (pKD>7.2).5.In conclusion, the evidence indicates that the presynaptic 5-HT autoreceptor belongs to the 5-HT1B receptor subtype.

[1]  J. Traber,et al.  3H-TVX Q 7821: identification of 5-HT1 binding sites as target for a novel putative anxiolytic , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  J. Gaddum,et al.  TWO KINDS OF TRYPTAMINE RECEPTOR , 1997, British journal of pharmacology and chemotherapy.

[3]  K. Starke Presynaptic receptors. , 1981, Annual review of pharmacology and toxicology.

[4]  F. Artaud,et al.  Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain. , 1984, European journal of pharmacology.

[5]  M. Göthert,et al.  Extracellular 5-hydroxytryptamine inhibits 5-hydroxytryptamine release from rat brain cortex slices , 1979, Naunyn-Schmiedeberg's Archives of Pharmacology.

[6]  J. Palacios,et al.  β-Adrenoceptor blocking agents recognize a subpopulation of serotonin receptors in brain , 1985, Brain Research.

[7]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[8]  E. Schlicker,et al.  Autoreceptor-mediated inhibition of 3H-5-hydroxytryptamine release from rat brain cortex slices by analogues of 5-hydroxytryptamine. , 1983, Life sciences.

[9]  E. Schlicker,et al.  Cyanopindolol is a highly potent and selective antagonist at the presynaptic serotonin autoreceptor in the rat brain cortex , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

[10]  Regulation of release processes in central serotoninergic neurons. , 1981, Journal de physiologie.

[11]  R. Furchgott The Classification of Adrenoceptors (Adrenergic Receptors). An Evaluation from the Standpoint of Receptor Theory , 1972 .

[12]  P. Waldmeier,et al.  Further evidence for negative feedback control of serotonin release in the central nervous system , 1981, Naunyn-Schmiedeberg's Archives of Pharmacology.

[13]  W. Vaatstra,et al.  Du 24565, a quipazine derivative, a potent selective serotonin uptake inhibitor. , 1981, European journal of pharmacology.

[14]  J. Leysen,et al.  [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. , 1982, Molecular pharmacology.

[15]  M. Göthert,et al.  Characterization of the receptor subtype involved in alpha-adrenoceptor-mediated modulation of serotonin release from rat brain cortex slices , 1981, Naunyn-Schmiedeberg's Archives of Pharmacology.

[16]  J. Palacios,et al.  Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors. , 1984, European journal of pharmacology.

[17]  S. Snyder,et al.  Two distinct central serotonin receptors with different physiological functions. , 1981, Science.

[18]  M. Göthert,et al.  Serotonin-receptor-mediated modulation of Ca2+-dependent 5-hydroxytryptamine release from neurones of the rat brain cortex , 1980, Naunyn-Schmiedeberg's Archives of Pharmacology.

[19]  D. Middlemiss Stereoselective blockade at [3H]5-HT binding sites and at the 5-HT autoreceptor by propranolol. , 1984, European journal of pharmacology.

[20]  J. Palacios,et al.  The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. , 1984, European journal of pharmacology.

[21]  E. Schlicker,et al.  Effects of DU 24565 (6-nitroquipazine) on serotoninergic and noradrenergic neurones of the rat brain and comparison with the effects of quipazine , 1984, Naunyn-Schmiedeberg's Archives of Pharmacology.

[22]  H A Feldman,et al.  Mathematical theory of complex ligand-binding systems of equilibrium: some methods for parameter fitting. , 1972, Analytical biochemistry.

[23]  J. Palacios,et al.  Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.

[24]  H. Yamamura,et al.  Discrimination of Multiple [3H]5‐Hydroxytryptamine Binding Sites by the Neuroleptic Spiperone in Rat Brain , 1981, Journal of neurochemistry.

[25]  E. sanders-Bush,et al.  Comparison of the pharmacological characteristics of 5 HT1 and 5 HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release , 1982, Naunyn-Schmiedeberg's Archives of Pharmacology.

[26]  M. Richards Efflux of 3H-5-hydroxytryptamine from rat hypothalamic slices by continuous electrical stimulation: Frequency-dependent responses to serotonergic antagonists and 5-hydroxytryptamine , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

[27]  D. Middlemiss 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site , 1984, Naunyn-Schmiedeberg's Archives of Pharmacology.

[28]  J. Fozard Functional correlates of 5-HT1 recognition sites , 1983 .

[29]  D. Hoyer,et al.  Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol. , 1985, European journal of pharmacology.

[30]  J. Glowinski,et al.  Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT , 1983, Nature.

[31]  R. Squires,et al.  Effects of 5HT uptake inhibitors on the pressor response to 5HT in the pithed rat. The significance of the 5HT blocking property. , 1977, European journal of pharmacology.

[32]  R. Lefkowitz,et al.  A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.

[33]  E. sanders-Bush,et al.  The serotonin autoreceptor: Antagonism by quipazine , 1982, Neuropharmacology.

[34]  R. Schnellmann,et al.  3H-serotonin binding sites: pharmacological and species differences. , 1983, Advances in biochemical psychopharmacology.

[35]  M. Göthert Modulation of serotonin release in the brain via presynaptic receptors , 1982 .

[36]  L. Sistonen,et al.  Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves , 1983, Naunyn-Schmiedeberg's Archives of Pharmacology.

[37]  E. Schlicker,et al.  Antagonistic properties of quipazine at presynaptic serotonin receptors and α-adrenoceptors in rat brain cortex slices , 1981, Naunyn-Schmiedeberg's Archives of Pharmacology.

[38]  D. Middlemiss,et al.  8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. , 1983, European journal of pharmacology.

[39]  S H Snyder,et al.  Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. , 1979, Molecular pharmacology.

[40]  D. Hoyer,et al.  Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. , 1985, European journal of pharmacology.

[41]  C. Moret,et al.  Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus. , 1982, The Journal of pharmacology and experimental therapeutics.